Literature DB >> 24830773

Feeding common carp Cyprinus carpio with β-glucan supplemented diet stimulates C-reactive protein and complement immune acute phase responses following PAMPs injection.

Nicolas Pionnier1, Alberto Falco2, Joanna J Miest3, Annette K Shrive4, Dave Hoole5.   

Abstract

The effect of β-glucan as a feed additive on the serum and gene profile of C-reactive protein (CRP) and complement acute phase responses was ascertained in common carp Cyprinus carpio. In addition effects of subsequent intraperitoneal injections of pathogen-associated molecular patterns (PAMPs), i.e. LPS or poly(I:C), to mimic bacterial or viral infection respectively, were studied. Carp were first orally fed with β-glucan (MacroGard®) with a daily β-glucan intake of 6 mg per kg body weight or with control food for 25 days and then injected with PBS containing either LPS (4 mg/kg) or poly(I:C) (5 mg/kg) or PBS alone. Fish were sampled during the 25 days of the feeding period and up to 7 days post-PAMPs injections for serum and liver, head kidney and mid-gut tissues. Oral administration of β-glucan for 25 days significantly increased serum CRP levels and alternative complement activity (ACP). In addition, the subsequent LPS and poly(I:C) challenges significantly affected CRP and complement related gene expression profiles (crp1, crp2, c1r/s, bf/c2, c3 and masp2), with the greatest effects observed in the β-glucan fed fish. However, in fish fed β-glucan the PAMPs injections had less effects on CRP levels and complement activity in the serum than in control fed fish, suggesting that the 25 days of β-glucan immunostimulation was sufficient enough to reduce the effects of LPS and poly(I:C) injections. Results suggest that MacroGard® stimulated CRP and complement responses to PAMPs immunological challenges in common carp thus highlighting the beneficial β-glucan immunostimulant properties.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRP; Complement; Cyprinus carpio; PAMPS; β-glucan

Mesh:

Substances:

Year:  2014        PMID: 24830773     DOI: 10.1016/j.fsi.2014.05.008

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  6 in total

1.  First Demonstration of Antigen Induced Cytokine Expression by CD4-1+ Lymphocytes in a Poikilotherm: Studies in Zebrafish (Danio rerio).

Authors:  Sohye Yoon; Suman Mitra; Cathy Wyse; Ayham Alnabulsi; Jun Zou; Eveline M Weerdenburg; Astrid M van der Sar; Difei Wang; Christopher J Secombes; Steve Bird
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

2.  Effect of Dietary Acidolysis-Oxidized Konjac Glucomannan Supplementation on Serum Immune Parameters and Intestinal Immune-Related Gene Expression of Schizothorax prenanti.

Authors:  Mingrui Chen; Shuyao Wang; Xue Liang; Donghui Ma; Li He; Yaowen Liu
Journal:  Int J Mol Sci       Date:  2017-11-28       Impact factor: 5.923

3.  Modulation of the Tissue Expression Pattern of Zebrafish CRP-Like Molecules Suggests a Relevant Antiviral Role in Fish Skin.

Authors:  Melissa Bello-Perez; Mikolaj Adamek; Julio Coll; Antonio Figueras; Beatriz Novoa; Alberto Falco
Journal:  Biology (Basel)       Date:  2021-01-22

Review 4.  Yeast β-Glucans as Fish Immunomodulators: A Review.

Authors:  Cristian Machuca; Yuniel Méndez-Martínez; Martha Reyes-Becerril; Carlos Angulo
Journal:  Animals (Basel)       Date:  2022-08-22       Impact factor: 3.231

5.  Zebrafish C-reactive protein isoforms inhibit SVCV replication by blocking autophagy through interactions with cell membrane cholesterol.

Authors:  Melissa Bello-Perez; Patricia Pereiro; Julio Coll; Beatriz Novoa; Luis Perez; Alberto Falco
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

Review 6.  Development of Fish Immunity and the Role of β-Glucan in Immune Responses.

Authors:  Marianna V Rodrigues; Fábio S Zanuzzo; João Fernando A Koch; Carlos Alberto F de Oliveira; Petr Sima; Vaclav Vetvicka
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.